Patents by Inventor Alex HARWIG

Alex HARWIG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic cancer-specific promoters
    Patent number: 12582726
    Abstract: Described herein are synthetic promoters and/or enhancers that are specific for cancer cells and methods of engineering synthetic cancer-specific promoters.
    Type: Grant
    Filed: May 23, 2025
    Date of Patent: March 24, 2026
    Assignee: EARLI Inc.
    Inventors: Dariusz Wodziak, Shireen Rudina, Maggie C. Louie, Yue Zhang, Elizabeth Stroebele, Albert Park, David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Leland Harrison Hartwell
  • Methods and compositions for synthetic biomarkers
    Patent number: 12448652
    Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
    Type: Grant
    Filed: August 18, 2023
    Date of Patent: October 21, 2025
    Assignee: EARLI Inc.
    Inventors: David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Shireen Rudina, Leland Harrison Hartwell
  • METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS
    Publication number: 20250144249
    Abstract: Biomarkers, affinity-based reagents, and methods of using such to detect, image, or treat cancer are described herein.
    Type: Application
    Filed: November 4, 2024
    Publication date: May 8, 2025
    Inventors: Alex HARWIG, Evan BISHOP, AMANDA KOHLER, David SUHY
  • METHODS AND COMPOSITIONS FOR SYNTHETIC BIOMARKERS
    Publication number: 20250064973
    Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
    Type: Application
    Filed: August 24, 2023
    Publication date: February 27, 2025
    Inventors: David SUHY, Paul ESCARPE, Cyriac ROEDING, Justin LIN, Alex HARWIG, Shireen RUDINA, Leland Harrison HARTWELL
  • METHODS AND COMPOSITIONS FOR SYNTHETIC BIOMARKERS
    Publication number: 20250060367
    Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
    Type: Application
    Filed: August 18, 2023
    Publication date: February 20, 2025
    Inventors: David SUHY, Paul ESCARPE, Cyriac ROEDING, Justin LIN, Alex HARWIG, Shireen RUDINA, Leland Harrison HARTWELL
  • Methods and compositions for synthetic biomarkers
    Patent number: 12060613
    Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: August 13, 2024
    Assignee: EARLI Inc.
    Inventors: David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Shireen Rudina, Leland Harrison Hartwell
  • METHODS AND COMPOSITIONS FOR SYNTHETIC BIOMARKERS
    Publication number: 20220275451
    Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
    Type: Application
    Filed: October 5, 2021
    Publication date: September 1, 2022
    Inventors: David SUHY, Paul ESCARPE, Cyriac ROEDING, Justin LIN, Alex HARWIG, Shireen RUDINA
  • METHODS AND COMPOSITIONS FOR SYNTHETIC BIOMARKERS
    Publication number: 20210277474
    Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
    Type: Application
    Filed: March 31, 2021
    Publication date: September 9, 2021
    Inventors: David SUHY, Paul ESCARPE, Cyriac ROEDING, Justin LIN, Alex HARWIG, Shireen RUDINA, Leland Harrison HARTWELL